StockNews.com assumed coverage on shares of Aspira Women’s Health (NYSE:AWH – Get Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the stock.
Aspira Women’s Health Trading Up 1.9 %
Shares of NYSE AWH opened at $0.58 on Tuesday. The company has a market capitalization of $72.39 million, a PE ratio of -2.15 and a beta of 2.89. Aspira Women’s Health has a fifty-two week low of $0.29 and a fifty-two week high of $1.29. The company’s 50-day moving average is $0.42.
Aspira Women’s Health (NYSE:AWH – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.03. The company had revenue of $2.07 million during the quarter, compared to analysts’ expectations of $2.40 million.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
- Get a free copy of the StockNews.com research report on Aspira Women’s Health (AWH)
- CVS Health Corporation Is Coiled And Ready To Spring Higher
- Will The Pullback In Paycom Payoff For Investors?
- TJX Among Apparel Retailers All Dressed Up & Ready For Growth
- Daqo New Energy Charged Up For New Highs
- No Spice In Chipotle Results, Is Now The Time To Buy?
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.